(Q51082851)

29 March 2018

title

Acute and chronic effects of gepirone and fluoxetine in rats tested in the elevated plus-maze: an ethological analysis (English)

1 reference

29 March 2018

1 reference

1 reference

2

1 reference

29 March 2018

author name string

Silva RC

series ordinal

1

1 reference

29 March 2018

language of work or name

English

0 references

publication date

1 February 2000

1 reference

29 March 2018

Pharmacology, Biochemistry and Behavior

published in

1 reference

29 March 2018

volume

65

1 reference

29 March 2018

issue

2

1 reference

29 March 2018

page(s)

209-216

1 reference

29 March 2018

Modification of 5-HT neuron properties by sustained administration of the 5-HT1A agonist gepirone: electrophysiological studies in the rat brain

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900193-8

7 January 2021

An ethological analysis of the effects of chlordiazepoxide and bretazenil (Ro 16-6028) in the murine elevated plus-maze

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900193-8

7 January 2021

Ethological evaluation of the effects of acute and chronic buspirone treatment in the murine elevated plus-maze test: comparison with haloperidol

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900193-8

7 January 2021

Ethopharmacological analysis of rat behavior on the elevated plus-maze.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900193-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900193-8

1 reference

7 January 2021

5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders: More than 30 years of research

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900193-8

7 January 2021

The use of the rat elevated plus-maze to discriminate between non-selective and BZ-1 (omega 1) selective, benzodiazepine receptor ligands

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900193-8

7 January 2021

Risk assessment behaviour: evaluation of utility in the study of 5-HT-related drugs in the rat elevated plus-maze test.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900193-8

7 January 2021

Effects of alpha-adrenoceptor agonists and antagonists in a maze-exploration model of ?fear?-motivated behaviour

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900193-8

7 January 2021

5HT drugs in animal models of anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900193-8

7 January 2021

Median raphe, but not dorsal raphe, application of the 5-HT1A agonist 8-OH-DPAT stimulates rat motor activity

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900193-8

7 January 2021

5-HT1A autoreceptors and the mode of action of selective serotonin reuptake inhibitors (SSRI)

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900193-8

7 January 2021

A review of the validity and variability of the elevated plus-maze as an animal model of anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900193-8

7 January 2021

Modulation of baseline behavior in rats by putative serotonergic agents in three ethoexperimental paradigms

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900193-8

7 January 2021

Ethologically-based animal models of anxiety disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900193-8

7 January 2021

Role of resocialization and of 5-HT1A receptor activation on the anxiogenic effects induced by isolation in the elevated plus-maze test

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900193-8

7 January 2021

The relation between fear induced by novel stimulation and exploratory drive

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900193-8

7 January 2021

Effects of blockade of 5-HT2 receptors and activation of 5-HT1A receptors on the exploratory activity of rats in the elevated plus-maze

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900193-8

7 January 2021

Imipramine in panic disorder. 1. Clinical response and pharmacological changes

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900193-8

7 January 2021

Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900193-8

7 January 2021

Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900193-8

7 January 2021

Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze test of anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900193-8

7 January 2021

Animal models of anxiety: an ethological perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900193-8

7 January 2021

Ethopharmacological analysis of 5-HT ligands on the rat elevated plus-maze

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900193-8

7 January 2021

Thigmotaxis as a test for anxiolytic activity in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900193-8

7 January 2021

Anxiogenic stimuli in the elevated plus-maze

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900193-8

7 January 2021

Subtypes of the 5-HT receptor mediating the behavioural responses to 5-methoxy-N,N-dimethyltryptamine in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900193-8

7 January 2021

10.1016/S0091-3057(99)00193-8

Identifiers

DOI

1 reference

29 March 2018

1 reference

29 March 2018